Walleye Trading LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$316,179
-51.9%
17,100
-18.6%
0.00%0.0%
Q4 2023$657,510
-11.7%
21,000
-41.2%
0.00%
-66.7%
Q3 2023$744,342
+137.2%
35,717
+172.6%
0.00%
+200.0%
Q2 2023$313,745
-47.2%
13,100
-58.5%
0.00%
-50.0%
Q1 2023$593,978
+87.1%
31,561
+58.3%
0.00%
+100.0%
Q4 2022$317,381
-38.7%
19,936
-37.0%
0.00%0.0%
Q3 2022$518,000
+62.9%
31,624
+40.0%
0.00%0.0%
Q2 2022$318,000
-66.3%
22,582
-42.1%
0.00%
-50.0%
Q1 2022$944,000
-13.3%
38,973
-16.5%
0.00%
-33.3%
Q4 2021$1,089,000
-15.1%
46,649
-39.6%
0.00%
-25.0%
Q3 2021$1,283,000
+95.6%
77,193
+187.0%
0.00%
+33.3%
Q2 2021$656,000
-88.6%
26,901
-80.0%
0.00%
-92.3%
Q4 2019$5,750,000
+666.7%
134,400
+545.3%
0.04%
+457.1%
Q3 2019$750,000
-62.6%
20,826
-72.3%
0.01%
-58.8%
Q2 2019$2,008,000
+1047.4%
75,100
+595.4%
0.02%
+1600.0%
Q4 2018$175,000
+8650.0%
10,800
+10700.0%
0.00%
Q3 2018$2,000
-86.7%
100
-81.4%
0.00%
Q2 2017$15,000
-96.6%
538
-95.8%
0.00%
-100.0%
Q1 2017$438,000
+3550.0%
12,728
+3082.0%
0.00%
Q4 2016$12,000
-36.8%
400
-33.3%
0.00%
Q3 2016$19,000
-80.4%
600
-79.9%
0.00%
-100.0%
Q2 2016$97,000
-92.8%
2,981
-93.9%
0.00%
-91.7%
Q1 2016$1,356,000
+545.7%
48,500
+725.5%
0.01%
+500.0%
Q4 2015$210,0005,8750.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 647,833$26,723,00011.32%
GREAT POINT PARTNERS LLC 1,921,563$79,264,0007.13%
Baker Brothers Advisors 41,904,586$1,728,564,0006.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 486,000$20,048,0006.47%
Palo Alto Investors LP 1,832,300$75,582,0004.15%
Birchview Capital, LP 204,000$8,416,0002.81%
SECTORAL ASSET MANAGEMENT INC 556,514$22,956,0001.97%
Rock Springs Capital Management LP 1,573,200$64,895,0001.65%
Riggs Asset Managment Co. Inc. 17,470$2,025,0000.85%
PFM Health Sciences, LP 421,087$17,370,0000.80%
View complete list of ACADIA PHARMACEUTICALS INC shareholders